Mark Mc Camish
Scientific Advisor
Nemesis Bioscience
United Kingdom
Biography
Mark led research and development of all biologics at Sandoz Biopharmaceuticals. His responsibilities included selection of the target, cloning, technical development, scale-up, pre-clinical and clinical development of biologics including interfaces with regulatory authorities worldwide. He is a senior executive with extensive therapeutic and commercial experience in global pharmaceutical and biotechnology companies. Previously he was Senior VP and Chief Medical Officer at PDL Biopharma, Facet Biotech and Perlegen. He also has held senior positions at Amgen and Abbott Laboratories.
Research Interest
Mark has research interest in Biology and Pharmaceutical industry.
